• |

Martha Luna, M.D.

Dr. Martha Luna joined RMA of New York in 2005 and is currently Co-Director of RMA of New York International, Mexico. She completed her fellowship in Reproductive Endocrinology and Infertility at Mount Sinai School of Medicine in New York City and is presently obtaining her Master’s degree in Clinical Embryology and Andrology at Eastern Virginia Medical School and The Jones Institute for Reproductive Medicine.

Before her fellowship, Dr. Luna was Chief Resident and graduated with an Honorable Mention in Excellence from The Institute of Technology and Superior Studies of Monterrey (ITESM).  She was recognized and awarded for her participation in Clinical Research and Investigation during her specialty in Obstetrics and Gynecology at Hospital San Jose-ITESM in the city of Monterrey. She obtained her Doctorate of Medicine with honors, being first in her class, from The University of Guadalajara.

Dr. Luna is the principal investigator for many studies and has published a significant number of insightful peer-reviewed articles and patient targeted fertility publications. Her areas of professional expertise include reproductive aging, recurrent pregnancy loss, in vitro-fertilization (IVF), and preimplantation genetic diagnosis (PGD). She has presented her research in multiple national and international scientific meetings.  Dr. Luna has lectured extensively, including on topics such as diminished ovarian reserve, in vitro fertilization, and preimplantation genetic diagnosis.

Dr. Luna is a member of the American College of Obstetrics and Gynecology (ACOG) and the American Society for Reproductive Medicine (ASRM).  She is board certified by the Mexico College of Obstetricians and Gynecologists.

The RMA Network

What's new?

Receive the latest updates from RMA!

RMANJ Research: Improving IVF

Original Research from RMANJ has Broad-Reaching Implications for Improving Success in IVF

Research Designated “Seminal Contribution” in April Issue of Fertility & Sterility

A new study conducted by Reproductive Medicine Associates of New Jersey has shown that an optimized method of Comprehensive Chromosome Screening (CCS) is the first technology capable of accurate aneuploidy screening (abnormal number of chromosomes) of all 24 chromosomes in four hours.

Learn more
Welcome to RMA of New York

This video introduces you to the world-renowned, full service fertility center, its Reproductive Endocrinologists, Urologist, Complementary Care team and highly qualified staff.

See Video